While germline mutations in BRCA1 account for 5% of breast cancer cases, evidence suggests that epigenetic silencing of BRCA1 by promoter hypermethylation and other mechanisms may contribute to up to 30% of sporadic breast cancers [2-7]. Here, BRCA1 is linked to breast carcinoma.